SETBP1 (SET-binding protein) variants and mutations
SETBP1 (also known as SET-binding protein) is a human protein-coding gene encoding a SET-binding protein. It regulates transcription and protein-phosphatase signaling in development and hematopoiesis. Specific gain-of-function variants cause Schinzel-Giedion syndrome, somatic hotspot variants occur in aggressive myeloid neoplasms, and loss-of-function variants can cause a distinct speech and developmental disorder. This analysis covers 2,534 SETBP1 variants and mutations. Of these, 70% have computational variant effect predictions. Disease context includes Schinzel-Giedion syndrome, intellectual disability, autosomal dominant 29, and chronic myelogenous leukemia, BCR-ABL1 positive. Example SETBP1 variants include E2K, E2D, and E2E.
Variant analysis overview
- Gene: SETBP1
- Protein: SET-binding protein
- UniProt accession: Q9Y6X0
- Organism: Homo sapiens
- Variants analyzed: 2534
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 2,255 unspecified-consequence records; 159 missense variants; 99 synonymous variants; 9 stop-gained variants; 8 frameshift variants; 1 splice-region variants; 1 in-frame deletions; 1 in-frame insertions; 1 substitution
- Prediction scores: 1,776 variants have prediction scores (70% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Schinzel-Giedion syndrome, intellectual disability, autosomal dominant 29, chronic myelogenous leukemia, BCR-ABL1 positive, myelodysplastic syndrome, acute myeloid leukemia, hereditary disease, Intellectual disability, juvenile myelomonocytic leukemia, hypertensive disorder, breast carcinoma, hearing loss disorder, Sensorineural hearing impairment.
Protein structure and variant hotspots
- Protein features: 1 post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable SETBP1 variants
Examples include E2K, E2D, E2E, S3C, S3S, R4G, R4R, R4M. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- E2K (p.Glu2Lys), gnomAD 18-44701350-G-A, CADD 27.70, PolyPhen-2 0.96
- E2D (p.Glu2Asp), gnomAD 18-44701352-G-T, CADD 24.20, PolyPhen-2 0.96
- E2E (p.Glu2Glu), gnomAD 18-44701352-G-A, CADD 9.80
- S3C (p.Ser3Cys), Ensembl rs762301342
- S3S (p.Ser3Ser), rs867812026, gnomAD 18-44701355-C-T, CADD 12.80
- R4G (p.Arg4Gly), rs1335280930, ClinGen CA402481247, ClinVar RCV002295820, Uncertain significance, not provided
- R4R (p.Arg4Arg), rs1335280930, gnomAD 18-44701356-A-C, CADD 13.30
- R4M (p.Arg4Met), gnomAD 18-44701357-G-T, CADD 26.60, PolyPhen-2 0.99
- T6P (p.Thr6Pro), Ensembl rs1599006504
- T6N (p.Thr6Asn), gnomAD 18-44701363-C-A, CADD 15.10, PolyPhen-2 0.00
- L7F (p.Leu7Phe), gnomAD 18-44701367-A-C, CADD 23.60, PolyPhen-2 0.66
- S8N (p.Ser8Asn), gnomAD 18-44701369-G-A, CADD 18.30, PolyPhen-2 0.15
- S8S (p.Ser8Ser), gnomAD 18-44701370-C-T, CADD 11.60
- S9G (p.Ser9Gly), rs2511331337, ClinGen CA402481284, ClinVar RCV003002150, Benign, not provided
- S9T (p.Ser9Thr), rs1343658768, ClinGen CA402481287, ClinVar RCV001986214, TOPMed rs1343658768, CADD 15.40, PolyPhen-2 0.00, Benign, not provided
- S9N (p.Ser9Asn), gnomAD 18-44701372-G-A, CADD 22.10, PolyPhen-2 0.21
- S9I (p.Ser9Ile), gnomAD 18-44701372-G-T, CADD 22.50, PolyPhen-2 0.03
- S9R (p.Ser9Arg), gnomAD 18-44701373-C-A, CADD 22.40, PolyPhen-2 0.21
- S10P (p.Ser10Pro), Ensembl rs2069112119
- S10C (p.Ser10Cys), gnomAD 18-44701375-C-G, CADD 19.10, PolyPhen-2 0.00
- R11G (p.Arg11Gly), rs776221622, ClinGen CA402481297, ClinVar RCV003717426, ExAC rs776221622, CADD 24.20, PolyPhen-2 0.70, Uncertain significance, not provided
- R11L (p.Arg11Leu), TOPMed rs535002208, gnomAD rs535002208, CADD 26.40, PolyPhen-2 0.97, Likely benign
- R11Q (p.Arg11Gln), rs535002208, ClinGen CA299822450, cosmic curated COSV56317, ClinVar RCV003090551, CADD 26.60, PolyPhen-2 0.96, Conflicting interpretations, Inborn genetic diseases; not provided
- R11W (p.Arg11Trp), rs776221622, ClinGen CA8945317, ClinVar RCV001940916, ExAC rs776221622, CADD 25.50, PolyPhen-2 0.99, Likely benign, not provided
- R11R (p.Arg11Arg), gnomAD 18-44701377-C-A, CADD 11.30
- Q12* (p.Gln12Ter), gnomAD 18-44701380-C-T, CADD 35.00
- R13T (p.Arg13Thr), gnomAD 18-44701384-G-C, CADD 23.30, PolyPhen-2 0.12
- R13K (p.Arg13Lys), gnomAD 18-44701384-G-A, MetaLR 0.28, MetaSVM -0.72
- G14R (p.Gly14Arg), Ensembl rs1317988090, CADD 26.00, PolyPhen-2 0.50
- G14W (p.Gly14Trp), gnomAD 18-44701386-G-T, MetaLR 0.57, MetaSVM -0.01
- G15D (p.Gly15Asp), rs551453904, ClinGen CA299822454, ClinVar RCV003238009, ExAC rs551453904, AlphaMissense 0.24, MetaLR 0.12, Uncertain significance, not provided
- G15S (p.Gly15Ser), gnomAD rs1272281074, CADD 12.80, PolyPhen-2 0.00
- G15V (p.Gly15Val), rs551453904, ClinGen CA8945318, ClinVar RCV003713876, ExAC rs551453904, AlphaMissense 0.24, MetaLR 0.12, Uncertain significance, not provided
- G15A (p.Gly15Ala), gnomAD 18-44701385-AG-A, CADD 27.40
- G15R (p.Gly15Arg), gnomAD 18-44701389-G-C, MetaLR 0.12, MetaSVM -0.99
- G15G (p.Gly15Gly), gnomAD 18-44701391-C-A, CADD 7.49
- E16K (p.Glu16Lys), rs587784381, ClinGen CA173411, cosmic curated COSV56320, ClinVar RCV000147470, CADD 24.10, PolyPhen-2 0.10, Conflicting interpretations, Inborn genetic diseases; not provided; Schinzel-Giedion syndrome
- E16R (p.Glu16Arg), rs1231303606, gnomAD 18-44701385-A-AG, CADD 28.30
- E16* (p.Glu16Ter), gnomAD 18-44701392-G-T, CADD 35.00
- E16Q (p.Glu16Gln), gnomAD 18-44701392-G-C, MetaLR 0.40, MetaSVM -0.33
- S17A (p.Ser17Ala), TOPMed rs1436724007, gnomAD rs1436724007, CADD 18.10, PolyPhen-2 0.01, Uncertain significance
- S17P (p.Ser17Pro), rs1436724007, ClinGen CA402481333, ClinVar RCV003692787, TOPMed rs1436724007, CADD 24.50, PolyPhen-2 0.65, Uncertain significance, not provided
- S17* (p.Ser17Ter), gnomAD 18-44701396-C-A, CADD 34.00
- S17S (p.Ser17Ser), gnomAD 18-44701397-A-G, CADD 8.03
- D18E (p.Asp18Glu), gnomAD rs1181828475, CADD 1.72, PolyPhen-2 0.00
- D18G (p.Asp18Gly), Ensembl rs2069112998, CADD 22.90, PolyPhen-2 0.13
- F19V (p.Phe19Val), rs2144195481, ClinGen CA402481348, cosmic curated COSV10802, ClinVar RCV001906207, AlphaMissense 0.27, MetaLR 0.27, Uncertain significance, not provided
- F19F (p.Phe19Phe), gnomAD 18-44701403-C-T, CADD 11.70
- L20P (p.Leu20Pro), rs2144195501, ClinGen CA402481357, ClinVar RCV002043028, Ensembl rs2144195501, AlphaMissense 0.23, MetaLR 0.26, Uncertain significance, not provided
- L20L (p.Leu20Leu), gnomAD 18-44701404-C-T, CADD 8.96
- P21L (p.Pro21Leu), rs758194735, ClinGen CA8945320, ClinVar RCV001814765, ClinVar RCV005732483, CADD 22.50, PolyPhen-2 0.01, Conflicting interpretations, Inborn genetic diseases; not provided
- P21S (p.Pro21Ser), gnomAD 18-44701407-C-T, MetaLR 0.09, MetaSVM -0.99
- P21T (p.Pro21Thr), gnomAD 18-44701407-C-A, MetaLR 0.11, MetaSVM -1.00
- P21R (p.Pro21Arg), gnomAD 18-44701408-C-G, MetaLR 0.18, MetaSVM -0.91
- P21Q (p.Pro21Gln), gnomAD 18-44701408-C-A, MetaLR 0.13, MetaSVM -0.97
- P21P (p.Pro21Pro), rs747925803, gnomAD 18-44701409-G-T, CADD 0.82
- V22D (p.Val22Asp), 1000Genomes rs185998256, gnomAD rs185998256, CADD 22.50, PolyPhen-2 0.05
- V22F (p.Val22Phe), TOPMed rs1187725431, gnomAD rs1187725431, CADD 22.80, PolyPhen-2 0.17
- V22I (p.Val22Ile), TOPMed rs1187725431, gnomAD rs1187725431, CADD 16.50, PolyPhen-2 0.02, Likely benign, not provided
- V22A (p.Val22Ala), gnomAD 18-44701411-T-C, MetaLR 0.11, MetaSVM -0.98
- V22V (p.Val22Val), gnomAD 18-44701412-C-A, CADD 7.03
- S23P (p.Ser23Pro), rs2144195665, ClinGen CA402481370, ClinVar RCV001974918, Ensembl rs2144195665, AlphaMissense 0.09, MetaLR 0.10, Benign, not provided
- S23S (p.Ser23Ser), rs1166375180, gnomAD 18-44701415-C-T, CADD 10.10
- S24L (p.Ser24Leu), rs2511331720, ClinGen CA402481380, ClinVar RCV003703488, Uncertain significance, not provided
- A25G (p.Ala25Gly), TOPMed rs2069113398
- A25S (p.Ala25Ser), gnomAD 18-44701419-G-T, MetaLR 0.12, MetaSVM -1.02
- A25V (p.Ala25Val), gnomAD 18-44701420-C-T, MetaLR 0.17, MetaSVM -0.89
- A25A (p.Ala25Ala), rs2069113448, gnomAD 18-44701421-C-G, CADD 9.08
- K26K (p.Lys26Lys), rs1599006678, gnomAD 18-44701424-G-A, CADD 9.69
- P27L (p.Pro27Leu), ExAC rs757122232, gnomAD rs757122232, CADD 22.80, PolyPhen-2 0.01, Uncertain significance, not provided
- P27S (p.Pro27Ser), rs751389887, ClinGen CA8945322, ClinVar RCV001913363, ClinVar RCV002555633, CADD 12.00, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases; not provided
- P27H (p.Pro27His), gnomAD 18-44701426-C-A, MetaLR 0.24, MetaSVM -0.75
- P27P (p.Pro27Pro), gnomAD 18-44701427-C-A, CADD 7.26
- P28L (p.Pro28Leu), rs915986492, ClinGen CA299822469, ClinVar RCV002947491, TOPMed rs915986492, CADD 9.65, PolyPhen-2 0.00, Uncertain significance, not provided
- P28Q (p.Pro28Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P28T (p.Pro28Thr), gnomAD 18-44701428-C-A, MetaLR 0.17, MetaSVM -0.94
- P28R (p.Pro28Arg), gnomAD 18-44701429-C-G, MetaLR 0.21, MetaSVM -0.89
- P28P (p.Pro28Pro), rs1372377435, gnomAD 18-44701430-A-G, CADD 0.91
- A29D (p.Ala29Asp), gnomAD rs1292543210, CADD 17.70, PolyPhen-2 0.03, Uncertain significance
- A29T (p.Ala29Thr), rs772172102, ClinGen CA8945325, cosmic curated COSV56332, ClinVar RCV002122722, CADD 9.20, PolyPhen-2 0.00, Benign/Likely benign, not provided
- A29V (p.Ala29Val), rs1292543210, ClinGen CA402481408, ClinVar RCV002017163, gnomAD rs1292543210, CADD 18.30, PolyPhen-2 0.00, Uncertain significance, not provided
- A29A (p.Ala29Ala), gnomAD 18-44701433-T-G, CADD 7.86
- A30T (p.Ala30Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A30V (p.Ala30Val), Ensembl rs2069113921, CADD 18.40, PolyPhen-2 0.00
- G32S (p.Gly32Ser), gnomAD 18-44701440-G-A, MetaLR 0.14, MetaSVM -1.01
- G32D (p.Gly32Asp), gnomAD 18-44701441-G-A, MetaLR 0.33, MetaSVM -0.46
- C33Y (p.Cys33Tyr), TOPMed rs1199198141, gnomAD rs1199198141, CADD 25.90, PolyPhen-2 0.74
- A34S (p.Ala34Ser), rs1234829999, ClinGen CA402481437, ClinVar RCV002293941, gnomAD rs1234829999, CADD 2.63, PolyPhen-2 0.00, Uncertain significance, not provided
- A34V (p.Ala34Val), rs2511331980, ClinGen CA402481440, ClinVar RCV002663207, CADD 19.80, PolyPhen-2 0.02, Uncertain significance, not provided
- A34A (p.Ala34Ala), rs572249525, gnomAD 18-44701448-A-C, CADD 13.40
- G35E (p.Gly35Glu), ExAC rs748268960, TOPMed rs748268960, gnomAD rs748268960, CADD 24.70, PolyPhen-2 0.91
- G35V (p.Gly35Val), ExAC rs748268960, TOPMed rs748268960, gnomAD rs748268960, CADD 25.10, PolyPhen-2 0.98
- G35G (p.Gly35Gly), rs772369656, gnomAD 18-44701451-A-G, CADD 8.82
- E36K (p.Glu36Lys), ExAC rs773643149, gnomAD rs773643149, CADD 24.00, PolyPhen-2 0.05
- E36Q (p.Glu36Gln), ExAC rs773643149, gnomAD rs773643149, CADD 23.50, PolyPhen-2 0.19
- E36E (p.Glu36Glu), gnomAD 18-44701454-A-G, CADD 9.87
- P37A (p.Pro37Ala), TOPMed rs985954731, gnomAD rs985954731, AlphaMissense 0.06, MetaLR 0.09, Uncertain significance
- P37H (p.Pro37His), rs747388683, ClinGen CA402481455, ClinVar RCV001971925, ExAC rs747388683, CADD 22.80, PolyPhen-2 0.00, Benign, not provided
- P37L (p.Pro37Leu), rs747388683, ClinGen CA8945331, cosmic curated COSV10586, ClinVar RCV001894433, CADD 23.10, PolyPhen-2 0.02, Likely benign, Inborn genetic diseases; not provided
- P37S (p.Pro37Ser), rs985954731, ClinGen CA402481454, ClinVar RCV002014932, TOPMed rs985954731, AlphaMissense 0.06, MetaLR 0.09, Uncertain significance, not provided
- P37T (p.Pro37Thr), cosmic curated COSV56338, TOPMed rs985954731, gnomAD rs985954731, Uncertain significance
- P37P (p.Pro37Pro), rs771548585, gnomAD 18-44701457-T-A, CADD 10.10
- L38S (p.Leu38Ser), rs2069114561, ClinGen CA402481460, ClinVar RCV002829501, TOPMed rs2069114561, AlphaMissense 0.17, MetaLR 0.39, Uncertain significance, not provided
- L39F (p.Leu39Phe), TOPMed rs2069114602, CADD 22.50, PolyPhen-2 0.32
- L39L (p.Leu39Leu), rs2144196326, gnomAD 18-44701463-C-T, CADD 7.06
- S40F (p.Ser40Phe), gnomAD 18-44701465-C-T, MetaLR 0.32, MetaSVM -0.53
- S40S (p.Ser40Ser), gnomAD 18-44701466-C-T, CADD 6.46
- T41S (p.Thr41Ser), TOPMed rs2069114707
- P42A (p.Pro42Ala), gnomAD 18-44701470-C-G, MetaLR 0.07, MetaSVM -1.01
- P42P (p.Pro42Pro), gnomAD 18-44701472-A-G, CADD 5.50
- P44R (p.Pro44Arg), rs2144196383, ClinGen CA402481497, ClinVar RCV001907439, Ensembl rs2144196383, AlphaMissense 0.16, MetaLR 0.16, Uncertain significance, not provided
- P44L (p.Pro44Leu), gnomAD 18-44701477-C-T, MetaLR 0.15, MetaSVM -0.91
- G45A (p.Gly45Ala), rs2511332234, ClinGen CA402481504, ClinVar RCV003699356, Uncertain significance, not provided
- G45R (p.Gly45Arg), gnomAD rs1258751538, CADD 23.80, PolyPhen-2 0.68
- G45G (p.Gly45Gly), gnomAD 18-44701481-G-A, CADD 10.20
- K46K (p.Lys46Lys), rs1486865751, gnomAD 18-44701484-G-A, CADD 9.55
- G47E (p.Gly47Glu), gnomAD 18-44701486-G-A, MetaLR 0.28, MetaSVM -0.44
- G47G (p.Gly47Gly), rs146868426, gnomAD 18-44701487-G-T, CADD 8.96
- I48M (p.Ile48Met), rs371516078, ClinGen CA16621717, ClinVar RCV000488064, ClinVar RCV004735569, CADD 17.10, PolyPhen-2 0.01, Uncertain significance, not provided
- I48I (p.Ile48Ile), rs371516078, gnomAD 18-44701490-C-T, CADD 9.19
- P49L (p.Pro49Leu), rs764706604, ClinGen CA8945335, cosmic curated COSV56320, ClinVar RCV002042435, CADD 19.00, PolyPhen-2 0.00, Uncertain significance, not provided
- P49T (p.Pro49Thr), cosmic curated COSV99951, ExAC rs759051569, gnomAD rs759051569
- P49S (p.Pro49Ser), gnomAD 18-44701491-C-T, MetaLR 0.11, MetaSVM -1.06
- P49P (p.Pro49Pro), rs775091518, gnomAD 18-44701493-G-A, CADD 1.17
- V50M (p.Val50Met), rs368634398, ClinGen CA8945337, ClinVar RCV001948382, ClinVar RCV005271535, CADD 23.60, PolyPhen-2 0.32, Likely benign, not provided; Inborn genetic diseases
- V50A (p.Val50Ala), gnomAD 18-44701495-T-C, MetaLR 0.14, MetaSVM -0.98
- G51G (p.Gly51Gly), rs372870881, gnomAD 18-44701499-C-A, CADD 1.35
- G52E (p.Gly52Glu), rs375461817, ClinGen CA8945340, ClinVar RCV003566837, ESP rs375461817, CADD 23.50, PolyPhen-2 0.29, Likely benign, not provided
- G52R (p.Gly52Arg), rs751299712, ClinGen CA8945339, ClinVar RCV002908415, ExAC rs751299712, CADD 24.80, Uncertain significance, not provided
- E53Q (p.Glu53Gln), cosmic curated COSV10586, Ensembl rs1568097438
- R54C (p.Arg54Cys), rs1325528399, ClinGen CA402481555, cosmic curated COSV56322, ClinVar RCV001774435, CADD 26.30, PolyPhen-2 0.72, Conflicting interpretations, not provided
- R54H (p.Arg54His), rs140717709, ClinGen CA8945342, cosmic curated COSV56330, ClinVar RCV002132313, CADD 23.90, PolyPhen-2 0.01, Benign/Likely benign, not provided
- R54L (p.Arg54Leu), rs140717709, ClinGen CA8945343, ClinVar RCV001884421, ClinVar RCV005863536, CADD 24.00, PolyPhen-2 0.20, Conflicting interpretations, not provided
- R54P (p.Arg54Pro), rs140717709, ClinGen CA299822525, ClinVar RCV002924337, 1000Genomes rs140717709, CADD 26.30, PolyPhen-2 0.60, Uncertain significance, Inborn genetic diseases
- R54S (p.Arg54Ser), TOPMed rs1325528399, gnomAD rs1325528399, CADD 21.50, Uncertain significance
- M55I (p.Met55Ile), rs778818507, ClinGen CA8945344, ClinVar RCV001542386, ClinVar RCV002570657, CADD 21.80, PolyPhen-2 0.00, Conflicting interpretations, Inborn genetic diseases; not provided; Schinzel-Giedion syndrome
- M55R (p.Met55Arg), Ensembl rs2069115638
- M55V (p.Met55Val), rs2511332508, ClinGen CA402481557, ClinVar RCV002800171, CADD 19.30, PolyPhen-2 0.00, Uncertain significance, not provided
- M55T (p.Met55Thr), gnomAD 18-44701510-T-C, MetaLR 0.21, MetaSVM -0.79
- E56D (p.Glu56Asp), gnomAD rs2060097582, CADD 22.30
- E56A (p.Glu56Ala), gnomAD 18-44701513-A-C, MetaLR 0.36, MetaSVM -0.09
- E56E (p.Glu56Glu), gnomAD 18-44701514-G-A, CADD 9.39
- P57L (p.Pro57Leu), rs1271534518, ClinGen CA402481576, cosmic curated COSV10940, ClinVar RCV002736238, AlphaMissense 0.13, MetaLR 0.40, Likely benign, not provided
- P57T (p.Pro57Thr), gnomAD 18-44701515-C-A, MetaLR 0.36, MetaSVM -0.37
- P57A (p.Pro57Ala), gnomAD 18-44701515-C-G, MetaLR 0.22, MetaSVM -0.71
- P57P (p.Pro57Pro), rs148596984, gnomAD 18-44701517-A-G, CADD 8.05
- E58Q (p.Glu58Gln), gnomAD 18-44701518-G-C, MetaLR 0.48, MetaSVM -0.06
- E58D (p.Glu58Asp), gnomAD 18-44701520-G-C, MetaLR 0.42, MetaSVM -0.07
- E59K (p.Glu59Lys), rs2069115926, ClinGen CA402481586, ClinVar RCV003691608, TOPMed rs2069115926, AlphaMissense 0.70, MetaLR 0.57, Uncertain significance, not provided
- E59E (p.Glu59Glu), gnomAD 18-44701523-G-A, CADD 8.24
- E60K (p.Glu60Lys), rs2069115983, ClinGen CA402481594, ClinVar RCV003722277, TOPMed rs2069115983, AlphaMissense 0.62, MetaLR 0.41, Uncertain significance, not provided
- E60E (p.Glu60Glu), gnomAD 18-44701526-G-A, CADD 11.00
- D61V (p.Asp61Val), NCI-TCGA Cosmic COSV5633, cosmic curated COSV56334, Variant assessed as somatic; moderate impact.
- E62V (p.Glu62Val), rs1029376020, ClinGen CA299822536, ClinVar RCV003880237, TOPMed rs1029376020, CADD 27.60, PolyPhen-2 0.93, Uncertain significance, not provided
- E62K (p.Glu62Lys), gnomAD 18-44701530-G-A, MetaLR 0.34, MetaSVM -0.48
- L63L (p.Leu63Leu), rs758634513, gnomAD 18-44701533-C-T, CADD 9.16
- L63R (p.Leu63Arg), gnomAD 18-44701534-T-G, MetaLR 0.30, MetaSVM -0.48
- G64D (p.Gly64Asp), gnomAD rs1486940365, CADD 25.00, PolyPhen-2 0.54, Likely benign, not provided
- G64V (p.Gly64Val), gnomAD rs1486940365, CADD 23.30, PolyPhen-2 0.05
- G64G (p.Gly64Gly), rs1203802037, gnomAD 18-44701538-C-T, CADD 10.80
- S65L (p.Ser65Leu), rs2511332776, ClinGen CA402481633, ClinVar RCV002462793, CADD 22.00, PolyPhen-2 0.02, Uncertain significance, not provided
- G66E (p.Gly66Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G66R (p.Gly66Arg), gnomAD 18-44701542-G-A, MetaLR 0.54, MetaSVM 0.07
- R67G (p.Arg67Gly), TOPMed rs955034546, gnomAD rs955034546, CADD 24.60, PolyPhen-2 0.76, Likely benign
- R67Q (p.Arg67Gln), rs778196366, ClinGen CA8945347, cosmic curated COSV10516, ClinVar RCV002049322, CADD 23.70, PolyPhen-2 0.79, Conflicting interpretations, not provided
- R67W (p.Arg67Trp), rs955034546, NCI-TCGA Cosmic COSV5631, cosmic curated COSV56316, CADD 25.30, PolyPhen-2 0.52, Likely benign
- R67R (p.Arg67Arg), rs955034546, gnomAD 18-44701545-C-A, CADD 11.60
- R67P (p.Arg67Pro), gnomAD 18-44701546-G-C, MetaLR 0.41, MetaSVM 0.01
- D68E (p.Asp68Glu), ExAC rs747370385, TOPMed rs747370385, gnomAD rs747370385, CADD 21.40, PolyPhen-2 0.97, Likely benign
- D68N (p.Asp68Asn), gnomAD 18-44701548-G-A, MetaLR 0.47, MetaSVM -0.07
- D68G (p.Asp68Gly), gnomAD 18-44701549-A-G, MetaLR 0.46, MetaSVM 0.17
- D68D (p.Asp68Asp), rs747370385, gnomAD 18-44701550-T-C, CADD 10.40
- V69G (p.Val69Gly), gnomAD rs1251298483, CADD 22.80, PolyPhen-2 0.28
- V69L (p.Val69Leu), NCI-TCGA TCGA novel, Ensembl rs2069116618, CADD 22.30, PolyPhen-2 0.20, Uncertain significance, not provided
- V69V (p.Val69Val), rs1004328008, gnomAD 18-44701553-G-A, CADD 10.50
- D70E (p.Asp70Glu), rs142975703, ClinGen CA8945349, ClinVar RCV003579145, ESP rs142975703, CADD 20.50, PolyPhen-2 0.13, Benign, not provided
- D70Y (p.Asp70Tyr), rs2069116787, ClinGen CA402481658, NCI-TCGA Cosmic COSV9995, cosmic curated COSV99952, AlphaMissense 0.89, MetaLR 0.48, Uncertain significance, not provided
- N72H (p.Asn72His), NCI-TCGA Cosmic COSV5633, cosmic curated COSV56336, Variant assessed as somatic; moderate impact.
- N72S (p.Asn72Ser), cosmic curated COSV99951, TOPMed rs1015494029, gnomAD rs1015494029, CADD 19.40, PolyPhen-2 0.03, Uncertain significance, not provided
- N72T (p.Asn72Thr), TOPMed rs1015494029, gnomAD rs1015494029, CADD 18.90
Public SETBP1 analysis runs
- SETBP1 analysis run — SETBP1 (2,534 variants) — completed 2026-08-19